Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,386 | 177 | 436 | 813 | 1,209 |
| Receivables | 40 | 19 | 20 | 24 | 146 |
| TOTAL | $1,979 | $227 | $633 | $1,174 | $1,604 |
| Non-Current Assets | |||||
| Intangibles | 4,248 | 4,381 | 4,515 | 4,650 | 4,785 |
| TOTAL | $4,248 | $4,381 | $4,515 | $4,650 | $4,785 |
| Total Assets | $6,227 | $4,608 | $5,148 | $5,824 | $6,390 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 956 | 205 | 80 | 98 | 67 |
| TOTAL | $1,046 | $314 | $155 | $184 | $146 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,374 | 1,353 | 1,333 | 1,314 | 1,296 |
| TOTAL | $1,374 | $1,353 | $1,333 | $1,314 | $1,296 |
| Total Liabilities | $2,420 | $1,667 | $1,488 | $1,498 | $1,441 |
| Shareholders' Equity | |||||
| Common Shares | 14,480 | 13,597 | 13,597 | 13,579 | 13,579 |
| Retained earnings | -12,498 | -11,678 | -10,925 | -10,203 | -9,556 |
| Other shareholders' equity | 378 | 78 | 78 | 75 | 75 |
| TOTAL | $3,807 | $2,941 | $3,660 | $4,327 | $4,948 |
| Total Liabilities And Equity | $6,227 | $4,608 | $5,148 | $5,824 | $6,390 |